Skip to main content
Top
Published in: Pituitary 4/2010

01-12-2010

Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing’s disease

Authors: Shrikrishna V. Acharya, Raju A. Gopal, Anurag Lila, Padma S. Menon, Tushar R. Bandgar, Nalini S. Shah

Published in: Pituitary | Issue 4/2010

Login to get access

Abstract

Paediatric Cushing’s disease (CD) is usually associated with growth retardation, but there are only few published data on skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84 years at diagnosis (range 9–19 years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child. BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables. BA delay was present in 35/48 (73%) patients (mean delay 1.6 years, range 0.5–5 years) and correlated negatively with height SDS (r = −0.594, P < 0.001) and positively with CA at diagnosis (r = 0.247, P < 0.05). There was no correlation with duration of symptoms before diagnosis, basal cortisol, midnight cortisol, ACTH or percentage suppression of low dose dexamethasone suppression cortisol (LDDST). We could not demonstrate any relationship between the duration of history before diagnosis and height SDS at final height. Mean final height SDS in patients was −1.84. We found that most children with CD had delayed BA and correlated significantly with CA and height SDS at diagnosis. Early diagnosis may reduce delay in skeletal maturation and thus contribute to optimal catch-up growth.
Literature
1.
go back to reference Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr et al (1994) Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331:629–636CrossRefPubMed Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr et al (1994) Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331:629–636CrossRefPubMed
2.
go back to reference Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA (1995) Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol (Oxf) 43:19–28CrossRef Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA (1995) Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol (Oxf) 43:19–28CrossRef
3.
go back to reference Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F et al (2005) Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466–472CrossRef Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F et al (2005) Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466–472CrossRef
4.
go back to reference Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265CrossRefPubMed Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265CrossRefPubMed
5.
go back to reference Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP (1994) Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J Clin Endocrinol Metab 78:131–137CrossRefPubMed Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP (1994) Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J Clin Endocrinol Metab 78:131–137CrossRefPubMed
6.
go back to reference Strickland AL, Underwood LE, Voina SJ, French FS, Van Wyk JJ (1972) Growth retardation in Cushing’s syndrome. Am J Dis Child 123:207–213PubMed Strickland AL, Underwood LE, Voina SJ, French FS, Van Wyk JJ (1972) Growth retardation in Cushing’s syndrome. Am J Dis Child 123:207–213PubMed
7.
go back to reference Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602CrossRefPubMed Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602CrossRefPubMed
8.
go back to reference Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective, long term study. Eur J Endocrinol 154:109–118CrossRefPubMed Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective, long term study. Eur J Endocrinol 154:109–118CrossRefPubMed
9.
go back to reference Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L, Ong KK, Dunger DB, Monson JP, Grossman AB, Besser GM, Savage MO (2007) Abnormal puberty in paediatric Cushing’s disease: relationship with adrenal androgen, sex hormone binding globulin, gonadotrophin concentrations. Clin Endocrinol (Oxf) 66(6):838–843CrossRef Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L, Ong KK, Dunger DB, Monson JP, Grossman AB, Besser GM, Savage MO (2007) Abnormal puberty in paediatric Cushing’s disease: relationship with adrenal androgen, sex hormone binding globulin, gonadotrophin concentrations. Clin Endocrinol (Oxf) 66(6):838–843CrossRef
10.
go back to reference Koedam JA, Smink JJ, Buul-Offers SC (2002) Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol 197:35–44CrossRefPubMed Koedam JA, Smink JJ, Buul-Offers SC (2002) Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol 197:35–44CrossRefPubMed
11.
go back to reference Lindberg MK, Vandenput L, Moverare SS, Vanderschueren D, Boonen S, Bouillon R et al (2005) Androgens and the skeleton. Minerva Endocrinol 30:15–25PubMed Lindberg MK, Vandenput L, Moverare SS, Vanderschueren D, Boonen S, Bouillon R et al (2005) Androgens and the skeleton. Minerva Endocrinol 30:15–25PubMed
12.
go back to reference Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425CrossRefPubMed Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425CrossRefPubMed
13.
go back to reference Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S (1992) Physical and sexual growth pattern of affluent Indian children from 5 to 18 years of age. Indian Pediatr 29:1203–1282PubMed Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S (1992) Physical and sexual growth pattern of affluent Indian children from 5 to 18 years of age. Indian Pediatr 29:1203–1282PubMed
14.
go back to reference Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, Grossman AB, Savage MO (2007) Factors influencing skeletal maturation at diagnosis of paediatric Cushing’s disease. Horm Res 68:231–235CrossRefPubMed Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, Grossman AB, Savage MO (2007) Factors influencing skeletal maturation at diagnosis of paediatric Cushing’s disease. Horm Res 68:231–235CrossRefPubMed
15.
go back to reference Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G et al (1998) Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139:3296–3305CrossRefPubMed Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G et al (1998) Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139:3296–3305CrossRefPubMed
16.
go back to reference Unterman TG, Phillips LS (1985) Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618–626CrossRefPubMed Unterman TG, Phillips LS (1985) Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618–626CrossRefPubMed
17.
go back to reference Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr (1992) Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263:E489–E492PubMed Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr (1992) Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263:E489–E492PubMed
18.
go back to reference Salt AT, Savage MO, Grant DB (1992) Growth patterns after surgery for virilising adrenocortical adenoma. Arch Dis Child 67:234–236CrossRefPubMed Salt AT, Savage MO, Grant DB (1992) Growth patterns after surgery for virilising adrenocortical adenoma. Arch Dis Child 67:234–236CrossRefPubMed
Metadata
Title
Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing’s disease
Authors
Shrikrishna V. Acharya
Raju A. Gopal
Anurag Lila
Padma S. Menon
Tushar R. Bandgar
Nalini S. Shah
Publication date
01-12-2010
Publisher
Springer US
Published in
Pituitary / Issue 4/2010
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-010-0246-3

Other articles of this Issue 4/2010

Pituitary 4/2010 Go to the issue